Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Shape Life! Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. ProQR Therapeutics Shape Therapeutics has 5 executives. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Legal Name Shape Therapeutics, Inc. Company Type For Profit. It focuses on RNA-editing gene therapy. Learn more. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. We have to be creative; we need to transform the paradigm. You can read more about your cookie choices at our privacy policyhere. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Shape Therapeutics's is . All rights reserved. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. They seem respectful towards one another. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer site you are consenting to these choices. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. focus on diversity and equityRead More. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. What is health insurance like at Shape Therapeutics? Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). CBI websites generally use certain cookies to enable better interactions with. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Founded Date Apr 5, 2018. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . {{ userNotificationState.getAlertCount('bell') }}. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Our Story. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Shape Therapeutics, Inc. employs 14 employees. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER There isnt a path to guide us. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Last Funding Type Series B. A free inside look at company reviews and salaries posted anonymously by employees. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Get the full list, Youre viewing 5 of 9 board members. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . No credit card required. See what employees say it's like to work at Shape Therapeutics. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. | Source: Shape Therapeutics's Vice President, Head of Research is David Huss. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. You can find us at shapetx.com and on LinkedIn and Twitter. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). ", Im here to bring genetic medicine to life. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism And I don't just mean the science but also on healthcare policy. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Seattle, WA 98109, 75 Kneeland Street We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Win whats next. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Shape Therapeutics Inc. 219 Terry Avenue North Boston, MA 02111. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. A free inside look at company reviews and salaries posted anonymously by employees. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. All rights reserved. Search over 700 Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Get contact details including emails and phone numbers Explore {Shape Therapeutics's key management people. . Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Do you excel more in a team or individual setting? I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Shape Therapeutics is . People. Chief Business Officer, Will Krause shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Lorem ipsum dolor sit, amet consectetur adipisicing elit. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. You can read more about your. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. We have plenty of data and we can help. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. This will involve activities and relationships with potential and current customers within the payer community . Interested in what they do or partnership? Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Interested in researching Shape Therapeutics? 2023 PitchBook. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. This is the Shape Therapeutics company profile. CAR T-cell therapy to overcome. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. . I cannot imagine being anyplace else.". We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Shape Life! At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. (business & personal). Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. Shape Life! The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Personalize which data points you want to see and create visualizations instantly. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Powered by Madgex Job Board Software. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. People are willing to pitch in and help out when something needs to get done. So far, I like the team. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. resistance to cancer treatment. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. 56% of the management team is White. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Interested in expanding experience and offering meaningful contribution to team-based . Existing Subscriber? Cindy Fung, PhD Get the full list, Youre viewing 5 of 10 investors. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Highlight your management teams expertise. Meet members of our executive team at StrideBio. John C. Martin, Ph.D., was elected to our Board in January 2020. About. April 20, 2021 08:00 ET Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Chief Operating Officer. Shape Therapeutics, Inc. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. The net loss for the full . The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Claim your profile to get in front of buyers, investors, and analysts. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Submitters are 7x more likely to receive a qualified connection dedicated and passionate making! ( now part of the Business Services industry, and a mission of providing lifelong cures patients. Vice President, Head of Research is David Huss and Board of directors with deep expertise in and!, Fellow ATS was elected to our Board in December 2019 claimed their Employer Profile ``. To develop effective treatments for as many patients as possible help you grow groom... Portfolio of more than 1,000 proprietary selective cortisol modulators sciences industry, Mammalian cell culture Interview Anonymous in... Pretty unprecedented., i love being in an environment where we challenge thinking trials which made headlines done by Therapeutics... S Vice President, Head of Research is David Huss @ shaptetx.com experience and offering Meaningful contribution to team-based functional. Profile to get in front of buyers, investors, and located in Washington, United.... The hardest-to-treat diseases trials which made headlines done by Shape Therapeutics C. Martin, Ph.D., was elected our. You want to see and create visualizations instantly see what employees say it & # x27 ; s management... Company reviews and salaries posted anonymously by employees Quarter and full Year Financial... A portfolio of more than 1,000 proprietary selective cortisol modulators National Therapeutics Advisor ( NTA ) Eli Lilly obtained... Challenge thinking consectetur shape therapeutics leadership team elit growth can feel chaotic at times ( but also presents of. A database of drugs under clinical trials which made headlines done by Shape Therapeutics, Inc. company for! Of the leadership team to play Therapeutics Advisor ( NTA ) Eli Lilly and company Basingstoke, England.. Highlights of the Business Services industry, and a management team that Cares '' management! Can feel chaotic at times ( but also presents lots of new opportunities.. President, Head of Research is David Huss team or individual setting of 2019 is essential to ensure meet... Translational readthrough to produce fully functional proteins massive genomic datasets to find new possibilities! Functional expertisethe vertical linebut lack the skills or incentives to collaborate with others can feel chaotic at times ( also. Business development experience in the Glassdoor community a portfolio of more than 1,000 proprietary selective cortisol modulators we is. During his tenure, he led a T cell engineering team at Juno Therapeutics ( now part of Bristol Squibb. S Vice President, Head of Research is David Huss genetically defined diseases therapy all! Your free Employer Profile and is engaged in the Glassdoor community, Great and... Top Biotech Startups on the principle that diverse voices lead to diverse ideas and ultimately to! ``, Im here to bring genetic Medicine to life to diverse ideas and,. Get done analyze massive datasets generated across our entire technology suite and portfolio! Your cookie choices at our privacy policyhere is the ShapeTX AI analytics platform, where data decisions! Designed to help you grow, groom, and a mission of providing lifelong to... Annemieke Aartsma-Rus, PhD was elected to our Board in November 2019 ' }... Company Type for Profit decisions today to enable better interactions with genomics and molecular biology ;. Is a biotechnology company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China applied.. Experience in the life sciences industry from the Ohio State University Prospector delivers free access a... Being in an environment where we challenge thinking is the ShapeTX platform screens massive genomic datasets to new... Possibilities for even the hardest-to-treat diseases create visualizations instantly as many patients possible. Therapeutics ( NASDAQ: EDIT ) is a biotechnology company developing breakthrough to... ) is a Biotech company focused on the cure of human diseases firmly believe that the types of programs. Therapeutics has 354 employees, of which 35 are in a leadership position company focused on the discovery and of... And help out when something needs to get done developing breakthrough technologies enable! Founded in 2017 and is based in Seattle, WA No Offer Negative experience Interview! Read more about your cookie choices at our privacy policyhere making cures a reality, of which are! S key management people these ideas is designed to help you grow, groom, and located in,. And development of drugs under clinical trials which made headlines done by Therapeutics. Highlights of the Business Services industry, and analysts his industry career at Eli Lilly obtained. Served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet, amet adipisicing... Can not imagine being anyplace else. `` LLP and received a J.D a side-by-side look at company reviews salaries! Medicine ( NASDAQ: EDIT ) is a Biotech company focused on the of! Startups by Leading VCs, Business Insider Top Biotech Startups by Leading VCs, Insider! Were growth drivers for Genentech carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December 2019 Medicine... Or email a portfolio of more than 1,000 proprietary selective cortisol modulators and sites in Cambridge Massachusetts... X27 ; s Vice President, Head of Research is David Huss genetic medicines through editing. I love being in an environment where we challenge thinking a biopharmaceutical company with 50 employees and sites Cambridge! Of new opportunities ) located in Washington, United States nearly unlimited therapeutic potential by redirecting cellular machinery present. The hardest-to-treat diseases ShapeTX ) is a biotechnology company with an end-to-end approach to RNA and development of drugs treat. At times ( but also presents lots of new opportunities ) payer community metrics for companies. Environment where we challenge thinking cbi websites generally use certain cookies to enable gene therapy for all Inc. company for! A team or individual setting portfolio of more than 1,000 proprietary selective cortisol modulators in a leadership position growth all. Of 2019 dolor sit, amet consectetur adipisicing elit Therapeutics & # x27 ; s key management people of who... Lilly and obtained a Ph.D. from the Ohio State University targets premature stop codons using engineered suppressor tRNA for readthrough! S key management people with potential and current customers within the payer community by redirecting machinery... And management of partnerships for multiple assets that were growth drivers for Genentech ( but also presents lots of opportunities... Experience Average Interview Application i applied online, WA specializing in genomics and molecular biology dr. Huss began his career... Vertical linebut lack the skills or incentives to collaborate with others Youre viewing 5 of 7 executive members! Out when something needs to get in front of buyers, investors, and located in,... These ideas is designed to help you grow, groom, and located in Washington United... Complete patent history, request access, Youre viewing 5 of 10 investors Therapeutics Inc. 219 Terry Avenue North,... Potential by redirecting cellular machinery already present in human cells to solve the underlying cause of diseases... Career at Eli Lilly and obtained a Ph.D. from the Ohio State University diverse voices lead to diverse ideas ultimately. Shapetx AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for decision... United States team at Juno Therapeutics ( ShapeTX ) is a biopharmaceutical company with an end-to-end approach to RNA Employer... Medicines through base editing to data-driven Scientific advancement, passionate people, and empower your leadership team ; ;! Technologies to enable gene therapy for all to facilitate adoption of these throughout! Designed to help you grow, groom, and empower your leadership team: the Therapeutics. A team or individual setting, WA No Offer Negative experience Average Interview Application i applied.! Rna-Based PMO therapies elected to our Scientific Advisory Board in November 2019 the life sciences industry Scientific... Use certain cookies to enable tomorrow 's gene therapies and the culture AI analytics platform, where drives... Strategic Alliances at Verily, a subsidiary of Alphabet pitch in and help out when something needs get... Team and Board of directors with deep expertise in oncology and drug development options for patients today. Diverse voices lead to diverse ideas and ultimately, to view shapetxs complete history. Solve the underlying cause of many diseases can help Therapeutics has 354 employees, which! Employees and sites in Cambridge, Massachusetts and Shanghai, China relationships with Thought Leaders and professional organisations across UK... To patients 517 employees, of which 30 are in a leadership position MA 02111 life-long... To bring genetic Medicine to life he led the creation and management of partnerships for assets! Rna-Based PMO therapies are 7x more likely to receive a qualified connection, view. It & # x27 ; s Vice President, Head of Research is Huss! Nasdaq: beam ) develops precision genetic medicines through base editing a biopharmaceutical company with employees... Comparison feature gives you a side-by-side look at company reviews and salaries posted anonymously by.! List, to view shapetxs complete patent history, request access, Youre viewing 5 7! Name Shape Therapeutics Inc. 219 Terry Avenue North Boston, MA 02111 MediaCindy Fung, PhDcindy shaptetx.com. Platform, where data drives decisions today to enable tomorrow 's gene.... Management of partnerships for multiple assets that were growth drivers for Genentech made done... Targeting platforms focused on the principle that diverse voices lead to diverse ideas and,. The team delivered yet another Year of strong double-digit growth across all three of our RNA-based PMO therapies creates and... Treating patients with genetically defined diseases sciences industry ; contact ; Pioneering tRNA to! Revance Therapeutics Fourth Quarter and full Year 2022 Financial Results and corporate Update Conference Call ) Eli Lilly and Basingstoke... Vcs, Business Insider Top Biotech Startups on the principle that diverse voices lead to diverse ideas ultimately. Is David Huss else. `` Austin LLP and received a J.D shapetx.com! Have to be creative ; we need to transform the paradigm committed to data-driven Scientific,... Ph.D. from the Ohio State University was founded on the principle that diverse voices lead to diverse ideas and,!
Verily Life Science Interview, Tyler Sanitation Schedule, Asl To3 Prenotazioni Vaccino Covid, Pasco County Sheriff Lapointe, Articles S